...
首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion
【24h】

Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion

机译:血管1A型血管紧张素II受体通过调节肾血流量和尿钠排泄来控制BP

获取原文
           

摘要

Inappropriate activation of the type 1A angiotensin (AT1A) receptor contributes to the pathogenesis of hypertension and its associated complications. To define the role for actions of vascular AT1A receptors in BP regulation and hypertension pathogenesis, we generated mice with cell-specific deletion of AT1A receptors in smooth muscle cells (SMKO mice) using Loxp technology and Cre transgenes with robust expression in both conductance and resistance arteries. We found that elimination of AT1A receptors from vascular smooth muscle cells (VSMCs) caused a modest (approximately 7 mmHg) yet significant reduction in baseline BP and exaggerated sodium sensitivity in mice. Additionally, the severity of angiotensin II (Ang II)–dependent hypertension was dramatically attenuated in SMKO mice, and this protection against hypertension was associated with enhanced urinary excretion of sodium. Despite the lower BP, acute vasoconstrictor responses to Ang II in the systemic vasculature were largely preserved (approximately 80% of control levels) in SMKO mice because of exaggerated activity of the sympathetic nervous system rather than residual actions of AT1B receptors. In contrast, Ang II–dependent responses in the renal circulation were almost completely eliminated in SMKO mice (approximately 5%–10% of control levels). These findings suggest that direct actions of AT1A receptors in VSMCs are essential for regulation of renal blood flow by Ang II and highlight the capacity of Ang II–dependent vascular responses in the kidney to effect natriuresis and BP control.
机译:1A型血管紧张素(AT1A)受体的激活不当会导致高血压及其相关并发症的发病机理。为了确定血管性AT1A受体在BP调节和高血压发病机制中的作用,我们使用Loxp技术和Cre转基因在电导和抗性中均表现出强健性,在平滑肌细胞中生成了具有细胞特异性缺失AT1A受体的小鼠(SMKO小鼠)动脉。我们发现,从血管平滑肌细胞(VSMC)消除AT1A受体会导致小鼠的基线BP适度(约7 mmHg)显着降低,并且钠敏感性增强。此外,SMKO小鼠中血管紧张素II(Ang II)依赖性高血压的严重程度显着减轻,这种针对高血压的保护作用与钠尿排泄的增加有关。尽管BP较低,但由于交感神经系统活动过度而不是AT1B受体的残留作用,SMKO小鼠在很大程度上保留了对全身血管系统中Ang II的急性血管收缩反应(约为对照水平的80%)。相比之下,SMKO小鼠几乎完全消除了依赖Ang II的肾脏循环反应(约占对照水平的5%–10%)。这些发现表明,VSMC中AT1A受体的直接作用对于Ang II调节肾血流至关重要,并突出了肾脏中依赖Ang II的血管反应影响利尿和BP控制的能力。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号